BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
Home
»
Authors
» Douglas Merrill
Douglas Merrill
Articles
ARTICLES
Financial Forum Attendees View Future With Cautious Optimism
June 23, 2004
By
Douglas Merrill
Icatibant Helps Jerini Raise EUR31M In Series B Financing
June 23, 2004
By
Douglas Merrill
Icatibant Helps Jerini Raise EUR31M In Series B Financing
June 23, 2004
By
Douglas Merrill
Financial Forum Attendees View Future With Cautious Optimism
June 23, 2004
By
Douglas Merrill
Wilex Initiates Phase III Study Of Renal-Cell Carcinoma Drug
June 16, 2004
By
Douglas Merrill
Wilex Initiates Phase III Study Of Renal-Cell Carcinoma Drug
June 16, 2004
By
Douglas Merrill
Phase II Results Open Pathway For Paion's EUR9.8M Fourth Round
May 26, 2004
By
Douglas Merrill
Phase II Results Open Pathway For Paion's EUR9.8M Fourth Round
May 26, 2004
By
Douglas Merrill
DeveloGen Finalizes Merger With Peptor, Raises EUR19M
May 19, 2004
By
Douglas Merrill
DeveloGen Finalizes Merger With Peptor, Raises EUR19M
May 19, 2004
By
Douglas Merrill
View All Articles by Douglas Merrill
